PATENT CLAIM ANALYSIS

Application Number: 15765048
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "279000"]

Abstract:
The invention concerns a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof as well as a pharmaceutical composition containing such a compound, and the use of such a compound as a drug, notably as a DNMT inhibitor, in particular in the treatment of cancer.

Claim (Index 32):
A pharmaceutical composition comprising at least one compound according to  claim 17 , and at least one pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11766171', '15566872', '14128516', '15023209', '14943931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7548807707425331
- 35 USC 102 Novelty (BERT): 0.5226089564775053
- Combined Prediction Score: 0.7316535893160303
- Mean Citation Score: 293.8900359999999
- Max Citation Score: 300.67657
- Similarity Product: 202.6611412473977

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test